Literature DB >> 8677598

Gangrene of the perineum.

E Benizri1, P Fabiani, G Migliori, D Chevallier, A Peyrottes, M Raucoules, J Amiel, J Mouiel, J Toubol.   

Abstract

Fournier's gangrene, an anaerobic necrotizing cellulitis of the infradiaphragmatic soft tissues, is a serious pathologic entity with an unpredictable course. From 1978 to 1991, a total of 24 men (mean age, 57 years; range 27 to 90) were treated for this entity at our institution. Diagnosis prompted immediate institution of multimodal treatment combining triple antibiotics, surgical dissection, debridement, and repeated surgical drainage. Fecal diversion (16 patients), hyperbaric oxygenation, and standard intensive care procedures were widely indicated and performed quasi-systematically. The mean interval between initial symptoms and diagnosis was 7.4 days. Lesions were limited to the perineum in 11 patients but extended to the abdomen, thighs, or loins in the remaining 13. The pathogens were identified in 19 patients, and hemoculture results were positive in 5. A coloproctologic origin was identified in 12 patients and a urogenital origin in 4. In 2 patients, perineal gangrene occurred postoperatively, and no etiology was determined for 6. Six patients died, and 18 patients recovered, without any sequelae. The prognosis is better when the patient is young (less than 60 years old), has clinically localized disease, without systemic involvement, and sterile hemocultures and is managed with colostomy. A thorough workup is mandatory to determine the etiology (locoregional lesion, malignancy, hemopathy, arteritis).

Entities:  

Mesh:

Year:  1996        PMID: 8677598     DOI: 10.1016/S0090-4295(96)00058-1

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  18 in total

1.  Comparison of Diverting Colostomy and Bowel Management Catheter Applications in Fournier Gangrene Cases Requiring Fecal Diversion.

Authors:  Ismail Cem Eray; Omer Alabaz; Atilgan Tolga Akcam; Abdullah Ulku; Cem Kaan Parsak; Gurhan Sakman; Gulsah Seydaoglu
Journal:  Indian J Surg       Date:  2013-01-27       Impact factor: 0.656

Review 2.  Fournier's gangrene and its emergency management.

Authors:  A Thwaini; A Khan; A Malik; J Cherian; J Barua; I Shergill; K Mammen
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

3.  The bittersweet demise of Herod the Great.

Authors:  W R Litchfield
Journal:  J R Soc Med       Date:  1998-05       Impact factor: 5.344

Review 4.  Rectal cancer and Fournier's gangrene - current knowledge and therapeutic options.

Authors:  Tomislav Bruketa; Matea Majerovic; Goran Augustin
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

5.  Penile reconstruction with dermal template and vacuum therapy in severe skin and soft tissue defects caused by Fournier's gangrene and hidradenitis suppurativa.

Authors:  Ingo Ludolph; Torsten Titel; Justus P Beier; Adrian Dragu; Marweh Schmitz; Bernd Wullich; Raymund E Horch
Journal:  Int Wound J       Date:  2014-02-21       Impact factor: 3.315

6.  Aggressiveness - the key to a successful outcome in Fournier's Gangrene.

Authors:  Gurjit Singh; S Chawla
Journal:  Med J Armed Forces India       Date:  2011-07-21

7.  Fournier's Gangrene: A Summary of 10 Years of Clinical Experience.

Authors:  Abdullah Oguz; Metehan Gümüş; Ahmet Turkoglu; Zübeyir Bozdağ; Burak Veli Ülger; Elif Agaçayak; Abdullah Böyük
Journal:  Int Surg       Date:  2015-04-10

8.  Prognostic factors and treatment outcomes for patients with Fournier's gangrene: a retrospective study.

Authors:  Kyung Sook Hong; Hee Jung Yi; Ryung-Ah Lee; Kwang Ho Kim; Soon Sup Chung
Journal:  Int Wound J       Date:  2017-09-25       Impact factor: 3.315

9.  Factitious Disorder Presenting with Attempted Simulation of Fournier's Gangrene.

Authors:  Joseph Tseng; Peter Poullos
Journal:  J Radiol Case Rep       Date:  2016-09-30

10.  Fournier's gangrene: is the female gender a risk factor?

Authors:  Ralf Czymek; Philine Frank; Stefan Limmer; Andreas Schmidt; Thomas Jungbluth; Uwe Roblick; Conny Bürk; Hans-Peter Bruch; Peter Kujath
Journal:  Langenbecks Arch Surg       Date:  2009-01-13       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.